Home · Healthcare M&A · Sell a Behavioral Health Practice in NJ or NY
Specialty Practice M&A · 2026
Behavioral health M&A in the tri-state is one of the most actively consolidated healthcare segments in 2026, driven by the growth of NY State Office of Mental Health (OMH) Article 31 MHOTRS (Mental Health Outpatient Treatment and Rehabilitative Services) programs and PE-backed behavioral health platforms. Multi-site Article 31 programs with $1M+ EBITDA command premium multiples. Substance use disorder treatment (SUD), child and adolescent mental health, and integrated medical-behavioral health programs each have distinct buyer pools and valuation profiles.
NJ behavioral health practices typically sell at 6×–10× EBITDA. The high end is driven by Article 31 / MHOTRS licensure (for NY programs), multi-site footprint, scale ($1M+ EBITDA), commercial-insurance payer mix, integrated medical-behavioral health offerings, and clean OMH/OASAS compliance history.
| Sub-specialty / Category | Typical Multiple |
|---|---|
| Multi-site Article 31 MHOTRS (NY) | 7×–10× EBITDA — premium segment |
| Multi-site NJ outpatient behavioral health | 6×–8× EBITDA |
| Solo/2-physician psychiatry practice | 4×–6× EBITDA |
| Substance use treatment (Article 32 NY) | 5×–8× EBITDA — payer-mix sensitive |
| Child and adolescent mental health | 6×–9× EBITDA — strong demand |
| Integrated medical-behavioral primary care | Premium PE interest, hospital system targets |
NY behavioral health M&A runs through NY State Office of Mental Health (OMH) for Article 31 MHOTRS programs and NY Office of Addiction Services and Supports (OASAS) for Article 32 SUD treatment programs. Ownership changes require OMH or OASAS approval — typical timeline 4–9 months. NY OMH approvals are typically faster than Article 28 PHHPC CONs because OMH focuses primarily on operator character, financial capacity, and program-quality continuity. NJ behavioral health practices operate under NJ Division of Mental Health and Addiction Services (DMHAS) for SUD programs. CMS PECOS re-enrollment, NY Medicaid eMedNY, and commercial payer credentialing must coordinate against close.
Multi-site Article 31 MHOTRS programs in NY typically sell at 7×–10× EBITDA. Multi-site NJ outpatient behavioral health practices trade at 6×–8×. Solo psychiatry practices trade at 4×–6×. Child and adolescent mental health practices trade at 6×–9× due to strong demand.
Pathways Health (Webster Equity), Refresh Mental Health (Kelso & Co), LifeStance Health (TPG), Mindpath Health, plus regional platforms (Acuity Behavioral Health) and several children's mental health specialty platforms. Hospital system behavioral health networks (RWJBarnabas, NYC Health + Hospitals, Mount Sinai) acquire affiliation interests.
Article 31 of NY Mental Hygiene Law (implemented as Mental Health Outpatient Treatment and Rehabilitative Services / MHOTRS since 2023) governs outpatient mental health programs in NY. MHOTRS licensure from NY OMH is the gating asset for premium PE acquisition interest — programs without OMH licensure cannot participate in the highest-value PE auctions. If you operate an outpatient behavioral health program in NY, MHOTRS licensure is essential before sale.
Typical NJ behavioral health practice sales close in 6–10 months. NY practices with Article 31 / MHOTRS or Article 32 / OASAS programs add OMH/OASAS ownership approval (4–9 months additional). Multi-site portfolios take 9–14 months due to per-site licensure transitions.
No. Success-only commission. You pay nothing until your practice sells.
Schedule a free confidential 30-minute conversation. We'll review your practice profile, give you a realistic valuation range, and tell you which PE platforms or strategic acquirers fit your specific situation. $0 upfront, no obligation.
Related: Healthcare M&A NJ pillar · Sell Your Clinic (Article 28/31) · Sell a Medical Practice · Healthcare M&A Glossary